BEZUCLASTINIB
UNII 2ROQ545LAG

Substance Identification & Data

This profile provides standardized clinical and technical data for Bezuclastinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2ROQ545LAG.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1616385-51-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2ROQ545LAG

CAS Registry Number

1616385-51-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BEZUCLASTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H17N5O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

NVSHVYGIYPBTEZ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C121647

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

75593308

Unique identification number in the NCBI database of chemical substances.

INN ID

12073

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-71

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N(c1cnc2[nH]c(-c3ccccc3)cc2c1)C(c4n[nH]c(C)c4C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bezuclastinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.